Blog
RSS FeedPosted by Michael Wonder on 28 Aug 2018
Cabometyx gets NICE recommendation in renal cell carcinoma
24 August 2018 - French drugmaker Ipsen that it has received a recommendation from NICE for National Health Service funding ...
Posted by Michael Wonder on 28 Aug 2018
Feedback encouraged to allow use of life extending treatment on NHS for those with blood cancer
28 August 2018 - CAR-T considered to be an exciting innovation which can cure some patients but very expensive. ...
Posted by Michael Wonder on 28 Aug 2018
NICE says ‘no’ to Gilead's Yescarta in draft guidelines
28 August 2018 - NHS funding for Gilead’s freshly approved CAR-T therapy Yescarta has been turned down in draft guidelines ...
Posted by Michael Wonder on 26 Aug 2018
Evidence required by heath technology assessment and reimbursement bodies evaluating diagnostic or prognostic algorithms that include omics data
23 August 2018 - Multi-analyte assays with algorithmic analyses use combinations of circulating and clinical markers including omics-based sources for diagnostic ...
Posted by Michael Wonder on 23 Aug 2018
NICE publishes preliminary guidance on new combo product for AML
23 August 2018 - The Department of Health and Social Care has asked NICE to produce guidance on using liposomal cytarabine ...
Posted by Michael Wonder on 23 Aug 2018
NICE publishes final guidance for dinutuximab
22 August 2018 - Dinutuximab is used to treat children with brain cancer. ...
Posted by Michael Wonder on 23 Aug 2018
Sobi secures NHS reimbursement for Ravicti
23 August 2018 - Rare disease group Swedish Orphan Biovitrum (Sobi) says it has gained NHS England reimbursement for Ravicti ...
Posted by Michael Wonder on 21 Aug 2018
No-deal Brexit could see hospitals run out of medicine, reveals leaked letter from health chief
21 August 2018 - Ministers and health service bosses have failed to prepare for UK crashing out of European Union, say ...
Posted by Michael Wonder on 21 Aug 2018
NHS managers warn no-deal Brexit risks drug shortages
21 August 2018 - NHS trusts are warning that the health service is not prepared for a no-deal Brexit and ...
Posted by Michael Wonder on 17 Aug 2018
NICE sticks with ‘no’ for use of Perjeta after breast cancer surgery
17 August 2018 - NICE is sticking with its position that Roche’s Perjeta is not cost-effective enough to be used ...
Posted by Michael Wonder on 16 Aug 2018
NICE publishes draft guidance on new cellular therapy for Crohn's disease
16 August 2018 - The Department of Health and Social Care has asked NICE to produce guidance on using darvadstrocel in ...
Posted by Michael Wonder on 16 Aug 2018
SMA groups outraged over UK rejection of Spinraza coverage as too expensive
16 August 2018 - Devastating. Heartbreaking. A death sentence for an estimated 1,000 children with spinal muscular atrophy (SMA). ...
Posted by Michael Wonder on 16 Aug 2018
Promising more appraisal capacity, NICE revives industry fee idea
10 August 2018 - Rising workload and shrinking budget making charges inevitable. ...
Posted by Michael Wonder on 15 Aug 2018
‘I wish they approved this new leukaemia drug two years ago, then I wouldn’t have had to go through hell’
12 August 2018 - Chloe Pinder was just 23 when she was diagnosed with acute lymphoblastic leukaemia, a very rare type ...
Posted by Michael Wonder on 15 Aug 2018
'You have the medicine that can make me feel much better': boy, 8, pens letter asking drug company to lower prices
14 August 2018 - Watch eight-year-old Luis Walker, who has cystic fibrosis, read his letter to a pharmaceutical company urging ...